GlaxoSmithKline PLC banner

GlaxoSmithKline PLC
LSE:GSK

Watchlist Manager
GlaxoSmithKline PLC Logo
GlaxoSmithKline PLC
LSE:GSK
Watchlist
Price: 1 921.5 GBX 0.95% Market Closed
Market Cap: £78B

Wall St Price Targets

GSK Price Targets Summary
GlaxoSmithKline PLC

Wall Street analysts forecast GSK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GSK is 2 149.96 GBX with a low forecast of 1 469.55 GBX and a high forecast of 2 887.5 GBX.

Lowest Forecast
Price Target
1 469.55 GBX
24% Downside
Average Forecast
Price Target
2 149.96 GBX
12% Upside
Highest Forecast
Price Target
2 887.5 GBX
50% Upside
GlaxoSmithKline PLC Competitors:
Price Targets
PACB
Pacific Biosciences of California Inc
83% Upside
FCBC
First Community Bankshares Inc
4% Upside
EVER
EverQuote Inc
35% Upside
UUU
3U Holding AG
68% Upside

Revenue
Forecast

2% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
2% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 3%.

Gross Profit
Forecast

2% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
2% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for GlaxoSmithKline PLC

Operating Income
Forecast

2% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
2% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 3%.

Pre-Tax Income
Forecast

1% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
1% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for GlaxoSmithKline PLC

Net Income
Forecast

2% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-23%
Average Miss
2% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-23%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 8 years is 4%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is GSK's stock price target?
Price Target
2 149.96 GBX

According to Wall Street analysts, the average 1-year price target for GSK is 2 149.96 GBX with a low forecast of 1 469.55 GBX and a high forecast of 2 887.5 GBX.

What is the Revenue forecast for GlaxoSmithKline PLC?
Projected CAGR
3%

Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 3%.

What is the Operating Income forecast for GlaxoSmithKline PLC?
Projected CAGR
3%

Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 3%.

What is the Net Income forecast for GlaxoSmithKline PLC?
Projected CAGR
4%

Over the last 13 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 8 years is 4%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett